ArticleJournal of lipid and atherosclerosis2020

Lipid-Lowering Efficacy and Safety of a New Generic Rosuvastatin in Koreans: an 8-Week Randomized Comparative Study with a Proprietary Rosuvastatin.

Hyoeun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.